ABM Clinical Protocol #18: Use of Antidepressants in Breastfeeding Mothers

Breastfeeding Medicine

Volumn 10, Issue 6, 2015, Pages 290-299

  Sriraman, Natasha K ^a   Melvin, Kathryn ^b   Meltzer Brody, Samantha ^b,c   Marinelli, Kathleen A ^d   Bunik, Maya ^d   Noble, Larry ^d   Brent, Nancy ^d   Lawrence, Ruth A ^d   Reece Stremtan, Sarah ^d   Rosen Carole, Casey ^d   Seo, Tomoko ^d   St Fleur, Rose ^d   Young, Michal ^d  

^a CHILDREN S HOSPITAL OF THE KING S DAUGHTERS   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ANXIETY DISORDER; ARTICLE; BREAST FEEDING; CLINICAL PROTOCOL; COGNITIVE THERAPY; DRUG EFFECT; DRUG USE; DSM-IV; EDINBURGH POSTNATAL DEPRESSION SCALE; FEMALE; HUMAN; INFANT FEEDING; INTERPERSONAL THERAPY; LACTATION; META ANALYSIS (TOPIC); MILK PRODUCTION; PRIORITY JOURNAL; PSYCHODYNAMIC PSYCHOTHERAPY; PSYCHOTHERAPY; PUERPERAL DEPRESSION; SCREENING; TREATMENT RESPONSE; ADVERSE EFFECTS; CLASSIFICATION; DEPRESSION, POSTPARTUM; INFANT; INFANT CARE; MEDICAL SOCIETY; MOTHER; PRACTICE GUIDELINE; PSYCHOLOGY; STANDARDS;

ANTIDEPRESSIVE AGENTS; BREAST FEEDING; CLINICAL PROTOCOLS; DEPRESSION, POSTPARTUM; FEMALE; HUMANS; INFANT; INFANT CARE; MOTHERS; SOCIETIES, MEDICAL;

EID: 84938078371     PISSN: 15568253     EISSN: 15568342     Source Type: Journal    
DOI: 10.1089/bfm.2015.29002     Document Type: Article

References (95)

1. Gjerdingen DK, Yawn BP. Postpartum depression screening: Importance, methods, barriers, and recommendations for practice. J Am Board Fam Med 2007;20: 280-288.
2. Chaudron LH, Szilagyi PG, Tang W, et al. Accuracy of depression screening tools for identifying postpartum depression among urban mothers. Pediatrics 2010;125: e609-e617.
3. Wisner KL, Perel JM, Peindl KS, et al. Prevention of recurrent postpartum depression: A randomized clinical trial. J Clin Psychiatry 2001;62:82-86.
4. Marcus SM. Depression during pregnancy: Rates, risks, and consequences-Motherisk Update 2008. Can J Clin Pharmacol 2009;16:e15-e22.
5. Oppo A, Mauri M, Ramacciotti D, et al. Risk factors for postpartum depression: The role of the Postpartum Depression Predictors Inventory-Revised (PDPI-R). Results from the Perinatal Depression-Research and Screening Unit (PNDReScU) study. Arch Womens Ment Health 2009;12: 239-249.
6. Cutler CB, Legano LA, Dreyer BP, et al. Screening for maternal depression in a low education population using a two item questionnaire. Arch Womens Ment Health 2007;10: 277-283.
7. Earls MF; Committee on Psychosocial Aspects of Child and Family Health American Academy of Pediatrics. Incorporating recognition and management of perinatal and postpartum depression into pediatric practice. Pediatrics 2010;126:1032-1039.
8. Mishina H, Takayama JI. Screening for maternal depression in primary care pediatrics. Curr Opin Pediatr 2009;21: 789-793.
9. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-V). American Psychiatric Publishing, Arlington, VA, 2013.
10. Sriraman NK. Postpartum depression: Why pediatricians should screen new moms. Cont Pediatr 2012;29:40-46.
11. Sharma V. Treatment of postpartum psychosis: Challenges and opportunities. Curr Drug Saf 2008;3:76-81.
12. Chaudron LH, Pies RW. The relationship between postpartum psychosis and bipolar disorder: A review. J Clin Psychiatry 2003;64:1284-1292.
13. Jones I, Craddock N. Familiarity of the puerperal trigger in bipolar disorder: Results of a family study. Am J Psychiatry 2001;158:913-917.
14. Abramowitz JS, Meltzer-Brody S, Leserman J, et al. Obsessional thoughts and compulsive behaviors in a sample of women with postpartum mood symptoms. Arch Womens Ment Health 2010;13:523-530.
15. Russell EJ, Fawcett JM, Mazmanian D. Risk of obsessivecompulsive disorder in pregnant and postpartum women: A meta-analysis. J Clin Psychiatry 2013;74:377-385.
16. National Institute for Health and Clinical Excellence. Postnatal Care: Routine Postnatal Care of Women and Their Babies (CG37). National Institute for Health and Clinical Excellence, London, 2006.
17. Royal Australian College of General Practitioners. Guidelines for Preventive Activities in General Practice. Royal Australian College of General Practitioners, East Melbourne, Australia, 2012.
18. Scottish Intercollegiate Guidelines Network. Management of Perinatal Mood Disorder. Scottish Intercollegiate Guidelines Network, Edinburgh, 2012.
19. Screening for perinatal depression. Committee Opinion No. 630. American College of Obstetricians and Gynecologists. Obstet Gynecol 2015;125:1268-1271. Available at www . acog. org/Resources-And-Publications/Committee-Opinions/ Committee-on-Obstetric-Practice/Screening-for-Perinatal-Depression (accessed June 1, 2015).
20. Yawn BP, Dietrich AJ, Wollan P, et al. TRIPPD: A practicebased network effectiveness study of postpartum depression screening and management. Ann Fam Med 2012;10: 320-329.
21. Appendix A Task Force Ratings. Guide to Clinical Preventive Services: Report of the U. S. Preventive Services Task Force, 2nd ed. Available at www. ncbi. nlm. nih. gov/ books/NBK15430/ (accessed May 27, 2015).
22. Olson AL, Kemper KJ, Kelleher KJ, et al. Primary care pediatricians' roles and perceived responsibilities in the identification and management of maternal depression. Pediatrics 2002;110:1169-1176.
23. Chaudron LH, Szilagyi PG, Campbell AT, et al. Legal and ethical considerations: Risks and benefits of postpartum depressions screening at well-child visits. Pediatrics 2007;119:123-128.
24. U. S. Public Health Service. Report of the Surgeon General's Conference on Children's Mental Health: A National Action Agenda. U. S. Department of Health and Human Services, Washington, DC, 2000. Available at www. ncbi. nlm. nih. gov/ books/NBK44233/ (accessed May 27, 2015).
25. Committee on the Psychosocial Aspects of Child and Family Health and Task Force on Mental Health. Policy statement-The future of pediatrics: Mental health competencies for pediatric primary care. Pediatrics 2009;124: 410-421.
26. Myers ER, Aubuchon-Endsley N, Bastian LA, et al. Efficacy and Safety of Screening for Postpartum Depression. Comparative Effectiveness Reviews, No. 106. Agency for Healthcare Research and Quality, Rockville, MD, 2013. Available at www. ncbi. nlm. nih. gov/books/NBK137724/ (accessed May 27, 2015).
27. Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry 1987;150:782-786. Available at http://pesnc. org/wp-content/uploads/EPDS. pdf (accessed May 27, 2015).
28. Hagan JF Jr, Shaw JS, Duncan P, eds. Bright Futures: Guidelines for Health Supervision of Infants, Children, and Adolescents, 3rd ed. American Academy of Pediatrics, Elk Grove Village, IL, 2008.
29. Sheeder J, Kabir K, Stafford B. Screening for postpartum depression at well-child visits: Is once enough during the first 6 months of life? Pediatrics 2009;123:e982-e988.
30. Freeman MP, Wright R, Watchman M, et al. Postpartum depression assessments at well-baby visits: Screening feasibility, prevalence, and risk factors. J Womens Health (Larchmt) 2005;14:929-935.
31. Dennis CL. Can we identify mothers at risk for postpartum depression in the immediate postpartum period using the Edinburgh Postnatal Depression Scale? J Affect Disord 2004;78:163-169.
32. Jardri R, Pelta J, Maron M, et al. Predictive validation study of the Edinburgh Postnatal Depression Scale in the first week after delivery and risk analysis for postnatal depression. J Affect Disord 2006;93:169-176.
33. Watkins S, Meltzer-Brody S, Zolnoun D, Stuebe A. Early breastfeeding experiences and postpartum depression. Obstet Gynecol 2011;118:214-221.
34. Trapolini T, McMahon CA, Ungerer JA. The effect of maternal depression and marital adjustment on young children's internalizing and externalizing behaviour problems. Child Care Health Dev 2007;33:794-803.
35. Minkovitz CS, O'Campo PJ, Chen YH, et al. Associations between maternal and child health status and patterns of medical care use. Ambul Pediatr 2002;2:85-92.
36. Kavanaugh M, Halterman JS, Montes G, et al. Maternal depressive symptoms are adversely associated with prevention practice and parenting behaviors for preschool children. Ambul Pediatr 2006;6:32-37.
37. Stuebe AM, Grewen K, Meltzer-Brody S. Association between maternal mood and oxytocin response to breastfeeding. J Womens Health (Larchmt) 2013;22:352-361.
38. Office of Disease Prevention and Health Promotion, U. S. Department of Health and Human Services. Healthy People 2020. Maternal, Infant, and Child Health. Available at http:// healthypeople. gov/2020/topicsobjectives2020/overview . aspx?topicid = 26 (accessed May 27, 2015).
39. Dennis CL, Ross LE, Grigoriadis S. Psychosocial and psychological interventions for treating antenatal depression. Cochrane Database Syst Rev 2007;(3):CD006309.
40. Brandon AR, Freeman MP. When she says 'no' to medication: Psychotherapy for antepartum depression. Curr Psychiatry Rep 2011;13:459-466.
41. Cuijpers P, Brannmark JG, van Straten A. Psychological treatment of postpartum depression: A meta-analysis. J Clin Psychol 2008;64:103-118.
42. O'Hara MW, Schlechte JA, Lewis DA, et al. Prospective study of postpartum blues. Biologic and psychosocial factors. Arch Gen Psychiatry 1991;48:801-806.
43. Dekker JJ, Koelen JA, Van HL, et al. Speed of action: The relative efficacy of short psychodynamic supportive psychotherapy and pharmacotherapy in the first 8 weeks of a treatment algorithm for depression. J Affect Disord 2008;109: 183-188.
44. O'Hara MW, Stuart S, Gorman LL, et al. Efficacy of interpersonal psychotherapy for postpartum depression. Arch Gen Psychiatry 2000;57:1039-1045.
45. Brandon AR, Ceccotti N, Hynan LS, et al. Proof of concept: Partner-assisted interpersonal psychotherapy for perinatal depression. Arch Womens Ment Health 2012;15: 469-480.
46. Mulcahy R, Reay RE, Wilkinson RB, et al. A randomised control trial for the effectiveness of group interpersonal psychotherapy for postnatal depression. Arch Womens Ment Health 2010;13:125-139.
47. Grote NK, Swartz HA, Geibel SL, et al. A randomized controlled trial of culturally relevant, brief interpersonal psychotherapy for perinatal depression. Psychiatr Serv 2009;60:313-321.
48. Burt VK, Suri R, Altshuler L, et al. The use of psychotropic medications during breast-feeding. Am J Psychiatry 2001;158:1001-1009.
49. Hale T. Medications and Mothers Milk, 16th ed. Hale Publishing, Plano, TX, 2014.
50. Weissman AM, Levy BT, Hartz AJ, et al. Pooled analysis of antidepressant levels in lactating mothers, breast milk, and nursing infants. Am J Psychiatry 2004;161:1066-1078.
51. Molyneaux E, Howard LM, McGeown HR, et al. Antidepressant treatment for postnatal depression. Cochrane Database Syst Rev 2014;9:CD002018.
52. Heikkinen T, Ekblad U, Kero P, et al. Citalopram in pregnancy and lactation. Clin Pharmacol Ther 2002;2: 184-191.
53. Lee A, Woo J, Ito S. Frequency of infant adverse events that are associated with citalopram use during breastfeeding. Am J Obstet Gynecol 2004;190:218-221.
54. Schmidt K, Olesen OV, Jensen PN. Citalopram and breastfeeding: Serum concentration and side effects in the infant. Biol Psychiatry 2000;47:164-165.
55. Bellantuono C, Bozzi F, Orsolini L, et al. The safety of escitalopram during pregnancy and breastfeeding: A comprehensive review. Hum Psychopharmacol 2012;27:534-539.
56. Brent NB, Wisner KL. Fluoxetine and carbamazepine concentrations in a nursing mother/infant pair. Clin Pediatr (Phila) 1998;37:41-44.
57. Kristensen JH, Ilett KF, Hackett LP, et al. Distribution and excretion of fluoxetine and norfluoxetine in human milk. Br J Clin Pharmacol 1999;48:521-527.
58. Epperson CN, Jatlow PI, Czarkowski K, et al. Maternal fluoxetine treatment in the postpartum period: Effects on platelet serotonin and plasma drug levels in breastfeeding mother-infant pairs. Pediatrics 2003;112:e425.
59. Heikkinen T, Ekblad U, Palo P, Laine K. Pharmacokinetics of fluoxetine and norfluoxetine in pregnancy and lactation. Clin Pharmacol Ther 2003;73:330-337.
60. Hendrick V, Stowe ZN, Altshuler LL, et al. Fluoxetine and norfluoxetine concentrations in nursing infants and breast milk. Biol Psychiatry 2001;50:775-782.
61. Suri R, Stowe ZN, Hendrick V, Hostetter A, et al. Estimates of nursing infant daily dose of fluoxetine through breast milk. Biol Psychiatry 2002;52:446-451.
62. Lester BM, Cucca J, Andreozzi L, et al. Possible association between fluoxetine hydrochloride and colic in an infant. J Am Acad Child Psychiatry 1993;32:1253-1255.
63. Chambers CD, Anderson PO, Thomas RG, et al. Weight gain in infants whose mothers take fluoxetine. Pediatrics 1999;104:e61.
64. Nightingale SL. Fluoxetine labeling revised to identify phenytoin interaction and to recommend against use in nursing mothers. JAMA 1994;271:106.
65. Arnold LM, Suckow RF, Lichtenstein PK. Fluvoxamine concentrations in breast milk and in maternal and infant sera. J Clin Psychopharmacol 2000;20:491-493.
66. Hagg S, Granberg K, Carleborg L. Excretion of fluvoxamine into breast milk. Br J Clin Pharmacol 2000;49:286-288.
67. Hendrick V, Fukuchi A, Altshuler L, et al. Use of sertraline, paroxetine and fluvoxamine by nursing women. Br J Psychiatry 2001;179:163-166.
68. Piontek CM, Wisner KL, Perel JM, Peindl KS. Serum fluvoxamine levels in breastfed infants. J Clin Psychiatry 2001;62:111-113.
69. Yoshida K, Smith B, Kumar RC. Fluvoxamine in breastmilk and infant development. Br J Clin Pharmacol 1997;44: 210-211.
70. Wright S, Dawling S, Ashford JJ. Excretion of fluvoxamine in breast milk. Br J Clin Pharmacol 1991;31:209.
71. Misery S, Kim J, Riggs KW, Kostaras X. Protein levels in postpartum depressed women, breast milk, and infant serum. J Clin Psychiatry 2000;61:828-832.
72. Stowe ZN, Cohen LS, Hostettler A, et al. Paroxetine in human breast milk and nursing infants. Am J Psychiatry 2000;157: 185-189.
73. Merlob P, Stahl B, Sulkes J. Paroxetine during breastfeeding: Infant weight gain and maternal adherence to counsel. Eur J Pediatr 2004;163:135-139.
74. Epperson CN, Anderson GM, McDougle CJ. Sertraline and breast-feeding. N Engl J Med 1997;336:1189-1190.
75. Stowe ZN, Owens MJ, Landry JC, et al. Sertraline and desmethylsertraline in human breast milk and nursing infants. Am J Psychiatry 1997;154:1255-1260.
76. Epperson N, Czarkowski KA, Ward-O'Brien D, et al. Maternal sertraline treatment and serotonin transport in breast-feeding mother-infant pairs. Am J Psychiatry 2001;158:1631-1637.
77. Wisner KL, Perel JM, Blumer J. Serum sertraline and Ndesmethylsertraline levels in breast-feeding mother-infant pairs. Am J Psychiatry 1998;155:690-692.
78. Dodd S, Stocky A, Buist A, et al. Sertraline analysis in the plasma of breast-fed infants. Aust N Z J Psychiatry 2001;35: 545-546.
79. Ito S, Koren G. Antidepressants and breast-feeding. Am J Psychiatry 1997;154:1174.
80. Olivier JD, Akerud H, Kaihola H, et al. The effects of maternal depression and maternal selective serotonin reuptake inhibitor exposure on offspring. Front Cell Neurosci 2013;7:73.
81. Austin MP, Karatas JC, Mishra P, et al. Infant neurodevelopment following in utero exposure to antidepressant medication. Acta Paediatr 2013;102:1054-1059.
82. Rampono J, Teoh S, Hackett LP, et al. Estimation of desvenlafaxine transfer into milk and infant exposure during its use in lactating women with postnatal depression. Arch Womens Ment Health 2011;14:49-53.
83. Ilett KF, Kristensen JH, Hackett LP, et al. Distribution of venlafaxine and its O-desmethyl metabolite in human milk and their effects in breastfed infants. Br J Clin Pharmacol 2002;53:17-22.
84. Boyce PM, Hackett LP, Ilett KF. Duloxetine transfer across the placenta during pregnancy and into milk during lactation. Arch Womens Ment Health 2011;14:169-172.
85. Baab SW, Peindl KS, Piontek CM, et al. Serum bupropion levels in two breastfeeding mother-infant pairs. J Clin Psychiatry 2002;63:910-911.
86. Neuman G, Colantonio D, Delaney S, et al. Bupropion and escitalopram during lactation. Ann Pharmacother 2014;48: 928-931.
87. Chaudron LH, Schoenecker CJ. Bupropion and breastfeeding: A case of a possible infant seizure. J Clin Psychiatry 2004;65:881-882.
88. Davis MF, Miller HS, Nolan PE Jr. Bupropion levels in breast milk for four mother-infant pairs: More answers to lingering questions. J Clin Psychiatry 2009;70:297-298.
89. Aichhorn WMD, Whitworth ABM, Weiss UMD, et al. Mirtazapine and breast-feeding. Am J Psychiatry 2004;161: 2325.
90. Wisner KL, Perel JM. Nortriptyline treatment of breastfeeding women. Am J Psychiatry 1996;153:295.
91. Wisner KL, Perel JM. Serum nortriptyline levels in nursing mothers and their infants. Am J Psychiatry 1991;148: 1234-1236.
92. Wisner KL, Perel JM, Findling RL, Hinnes RL. Nortriptyline and its hydroxymetabolites in breastfeeding mothers and newborns. Psychopharmacol Bull 1997;33:249-251.
93. Frey OR, Scheidt P, von Brenndorff AI. Adverse effects in a newborn infant breast-fed by a mother treated with doxepin. Ann Pharmacother 1999;33:690-693.
94. Freeman MP, Hibbeln JR, Wisner KL, et al. Randomized dose-ranging pilot trial of omega-3 fatty acids for postpartum depression. Acta Psychiatr Scand 2006;113:31-35.
95. Lee A, Minhas R, Matsuda N, et al. The safety of St. John's wort (Hypericum perforatum) during breast-feeding. J Clin Psychiatry 2003;64:966-968.